Abstract

Background: mRNA COVID-19 vaccines employ messenger RNA (mRNA) to convey instructions to cells in our bodies, prompting them to generate a viral protein. These vaccines are administered via injection, typically into the upper arm muscle. The mRNA is encapsulated within lipid nanoparticles, safeguarding it and facilitating its entry into cells. Method: The literature about the specific cells and places where the mRNA of COVID-19 vaccines is supposed to work following injection in the upper arm is reviewed. Results: The pre-COVID-19 literature indicates that the absorption of mRNA primarily takes place not at the injection site in the arm muscle, but rather in the lymph nodes downstream from the injection site and in the spleen. Lipid nanoparticles could potentially accumulate in the liver as well. As the narrative promoted by Western media and authorities claims that the mRNA is immediately released by the lipidic nanoparticles and exclusively operates within specific cells at the injection site before being quickly discharged, consequently, the post-COVID-19 literature has become less explicit on this matter, as censorship has hampered open discussion within the scientific community. Conclusions: The mRNA of COVID-19 vaccines has always been supposed to work in the lymph nodes downstream of the place of injection and the spleen. This may explain the large number of unintended effects recorded following administration of mRNA COVID-19 vaccines.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call